Browse the evidence

Participants treated with SAR425899 lost more weight, fat mass, and fat free mass compared to those on placebo (p < 0.05).

SAR425899 may enhance weight loss and body composition improvements.

Postpartum weight gain was the result of increased energy intake after pregnancy rather than decreased energy expenditure.

Women with obesity should be advised on managing energy intake after pregnancy to prevent weight retention.

Women with postpartum weight loss reduced energy intake during the postpartum period by 300 kcal/d.

Encouraging reduced energy intake can aid in postpartum weight loss for women with obesity.

Plant-based dietary patterns rich in minimally processed foods, vegetables, and fruits reduce CVD risk.

Health professionals should recommend plant-based diets rich in whole foods to reduce CVD risk.

The Mediterranean, Dietary Approaches to Stop Hypertension, and vegetarian diets reduce CVD risk.

Health professionals should promote these specific dietary patterns to lower CVD risk.

Tirzepatide administration for 72 weeks elicited significant weight reduction ranging from 5% to 20.9% across different trials in a dose-dependent manner.

Tirzepatide may be an effective option for weight management in patients with obesity and T2DM.

Both American and European guidelines encourage heart-healthy diets consistent with Mediterranean, DASH, or healthy vegetarian patterns.

Clinicians should recommend these dietary patterns for CVD prevention.

Semaglutide showed the most significant weight reduction among patients with IBD.

Semaglutide may be effective for weight management in IBD patients.

Consumption of certain foods, such as beans, should be increased due to their positive health effects.

Encouraging the consumption of beans can be beneficial for health.

Increasing physical activity may help maintain diet-induced body mass loss in the long term.

Encouraging clients to increase physical activity can support long-term weight loss maintenance.

The SMM/ECW ratio decreased only in the creatine group.

Creatine supplementation may alter the balance of muscle mass to extracellular water in resistance-trained individuals.

Semaglutide led to a weight reduction of 9.21 kg in the study population.

Semaglutide may assist in significant weight loss for patients in this demographic.

Combined nutrition and exercise interventions significantly reduced body weight by 2.13 kg (95%CI, -3.07 to -1.19) in adults with cancer.

Practitioners can consider combined nutrition and exercise interventions as effective strategies for weight management in cancer patients.

Combined nutrition and exercise interventions significantly reduced fat mass by 2.06 kg (95%CI, -3.02 to -1.09) in adults with cancer.

Practitioners can utilize combined nutrition and exercise interventions to effectively reduce fat mass in cancer patients.

Worksite wellness programs (WWPs) increased intake of fruits and vegetables (F&amp;V), especially fruits.

Practitioners can implement WWPs to enhance fruit and vegetable consumption among employees.

WWPs reduced BMI by a mean of -0.64 kg/m² for interventions lasting less than 12 months and -0.16 kg/m² for those lasting 12 months or more.

Practitioners should consider the duration of WWPs when aiming for BMI reduction.

WWPs reduced waist circumference (WC) by a mean of -2.03 cm.

Implementing WWPs can lead to significant reductions in waist circumference.

A national 10% price reduction on fruits, vegetables, nuts, and whole grains is estimated to prevent 19,600 CMD deaths/year.

Implementing a 10% price reduction on healthy foods could significantly reduce CMD mortality.

Suboptimal diet is the leading risk factor for poor health in nearly every region.

Health practitioners should prioritize addressing dietary issues as a key factor in health.

The efficacy of eccentric overload training for enhancing muscle growth is examined.

The findings may provide insights into the effectiveness of eccentric overload training for muscle growth.

The working group recommends dietary consultations, increased physical activity, resistance training, and potential use of oral nutritional supplements and medications for managing sarcopenic obesity.

Practitioners should consider these recommendations for effective management of sarcopenic obesity.

Resistance-based exercise programs resulted in a significant change of -1.6 kg in whole-body fat mass (95% CI = -1.9 to -1.3 kg, P < 0.001).

Resistance training can effectively reduce body fat in overweight and obese individuals.

Semaglutide has been shown to result in a loss of almost 12% of body weight over a 68-week period.

Semaglutide can be considered an effective option for significant weight loss in eligible patients.

Supplementation with long-chain omega-3 fatty acids and increasing the consumption of alpha-linolenic and linoleic acids in place of saturated fats reduced the risk of coronary events.

Encouraging omega-3 supplementation and specific fatty acid intake may help reduce coronary event risk.